Kirsten Grønbæk

Kirsten Grønbæk

Clinical Professor

Member of:

  • Internal Medicine: Haematology


Publication year:
All
41 - 50 out of 171Page size: 10
  1. 2022
  2. Published

    Clonal hematopoiesis is associated with hematological toxicity during lenalidomide-based therapy for MCL

    Husby, Simon, Bæch-Laursen, C., Eskelund, C. W., Favero, Francesco, Jespersen, Jakob Schmidt, Hutchings, M., Pedersen, L. B., Niemann, Carsten, Weischenfeldt, Joachim Lütken, Räty, R., Larsen, T. S., Kolstad, A., Jerkeman, M. & Grønbæk, Kirsten, 2022, In: Leukemia. 36, p. 2912-2916

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Level of unique T cell clonotypes is associated with clonal hematopoiesis and survival in patients with lymphoma undergoing ASCT

    Husby, Simon, Jørgensen, G. Ø., Favero, Francesco, Jespersen, Jakob Schmidt, Rodriguez Gonzalez, Francisco G, Nielsen, C., Sorensen, B., Ebbesen, L. H., Bæch, J., Haastrup, E. K., Josefsson, P., Thorsgaard, M., Brown, Peter de Nully, El-Galaly, T. C., Larsen, T. S., Weischenfeldt, Joachim Lütken & Grønbæk, Kirsten, 2022, In: Bone Marrow Transplantation. 57, p. 674-677

    Research output: Contribution to journal › Letter › Research › peer-review

  4. Published

    Experiences and Needs of Caregivers of Adult Patients With Hematologic Malignancies During Treatment: A Qualitative Longitudinal Study

    Husted Nielsen, I., Piil, K., Grønbæk, Kirsten, Kjeldsen, L. & Jarden, Mary Ellen, 2022, In: Cancer Nursing. 45, 5, p. E801-E809

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    Family caregiver ambassador support for caregivers of patients with newly diagnosed hematological cancer: a feasibility study

    Husted Nielsen, I., Piil, K., Tolver, Anders, Grønbæk, Kirsten, Kjeldsen, L. & Jarden, Mary Ellen, 2022, In: Supportive Care in Cancer. 30, 8, p. 6923-6935 13 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    Socioeconomic position and clinical outcomes in patients with myelodysplastic syndromes: A population-based cohort study

    Lauritsen, T. B., Østgård, L. S. G., Grønbæk, Kirsten, Dalton, Susanne Oksbjerg & Nørgaard, J. M., 2022, In: Hematological Oncology. 40, 5, p. 1056-1066

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Published

    Pre-treatment health-related quality of life parameters have prognostic impact in patients >65 years with newly diagnosed mantle cell lymphoma: The Nordic Lymphoma Group MCL4 (LENA-BERIT) experience

    Lindberg, Å., Eskelund, C. W., Albertsson-Lindblad, A., Kolstad, A., Laurell, A., Räty, R., Grønbæk, Kirsten, Geisler, C. H. & Jerkeman, M., 2022, In: Hematological Oncology. 40, 1, p. 23-31

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    Serum proteome modulations upon treatment provides biological insight on response to treatment in relapsed mantle cell lymphoma

    Lokhande, L., Kuci Emruli, V., Eskelund, C. W., Kolstad, A., Hutchings, M., Räty, R., Niemann, Carsten, Grønbæk, Kirsten, Jerkeman, M. & Ek, S., 2022, In: Cancer Reports. 5, 8 p., e1524.

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    Inflammatory Cytokine Profiles Do Not Differ Between Patients With Idiopathic Cytopenias of Undetermined Significance and Myelodysplastic Syndromes

    Nielsen, A. B., Hansen, Jakob Werner, mxz703, mxz703, Dimopoulos, K., Salem, M., Grigorian, M., Bruunsgaard, Helle & Grønbæk, Kirsten, 2022, In: HemaSphere. 6, 5, 10 p., e0713.

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    Safety, Outcomes, and T-Cell Characteristics in Patients with Relapsed or Refractory MDS or CMML Treated with Atezolizumab in Combination with Guadecitabine

    O'Connell, C. L., Baer, M. R., Ørskov, A. D., Saini, S. K., Duong, V. H., Kropf, P., Hansen, J. W., Tsao-Wei, D., Jang, H. S., Emadi, A., Holmberg-Thyden, S., Cowland, J., Brinker, B. T., Horwood, K., Burgos, R., Hostetter, G., Youngblood, B. A., Hadrup, S. R., Issa, J. P., Jones, P. & 3 others, Baylin, S. B., Siddiqi, I. & Grønbæk, Kirsten, 2022, In: Clinical cancer research : an official journal of the American Association for Cancer Research. 28, 24, p. 5306-5316 11 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  11. Published

    "Randomized phase II study of azacitidine ± lenalidomide in higher-risk myelodysplastic syndromes and acute myeloid leukemia with a karyotype including Del(5q)"

    Rasmussen, B., Gohring, G., Bernard, E., Nilsson, L., Tobiasson, M., Jadersten, M., Garelius, H., Dybedal, I., Gronbaek, K., Ejerblad, E., Lorenz, F., Flogegard, M., Marcher, C. W., oster Fernstrom, A., Cavelier, L., Papaemmanuil, E., Ebeling, F., Kittang, A. O., Norgaard, J. M., Saft, L. & 2 others, Mollgard, L. & Hellstrom-Lindberg, E., May 2022, In: Leukemia. 36, 5, p. 1436-1439 4 p.

    Research output: Contribution to journal › Letter › Research › peer-review

Previous 1 2 3 4 5 6 7 8 ...18 Next

ID: 37722667